Literature DB >> 31106880

Explaining Pathogenicity of Congenital Zika and Guillain-Barré Syndromes: Does Dysregulation of RNA Editing Play a Role?

Helen Piontkivska1,2, Noel-Marie Plonski2, Michael M Miyamoto3, Marta L Wayne3,4.   

Abstract

Previous studies of Zika virus (ZIKV) pathogenesis have focused primarily on virus-driven pathology and neurotoxicity, as well as host-related changes in cell proliferation, autophagy, immunity, and uterine function. It is now hypothesized that ZIKV pathogenesis arises instead as an (unintended) consequence of host innate immunity, specifically, as the side effect of an otherwise well-functioning machine. The hypothesis presented here suggests a new way of thinking about the role of host immune mechanisms in disease pathogenesis, focusing on dysregulation of post-transcriptional RNA editing as a candidate driver of a broad range of observed neurodevelopmental defects and neurodegenerative clinical symptoms in both infants and adults linked with ZIKV infections. The authors collect and synthesize existing evidence of ZIKV-mediated changes in the expression of adenosine deaminases acting on RNA (ADARs), known links between abnormal RNA editing and pathogenesis, as well as ideas for future research directions, including potential treatment strategies.
© 2019 WILEY Periodicals, Inc.

Entities:  

Keywords:  Guillain-Barré syndrome (GBS); RNA editing; Zika virus (ZIKV); adenosine deaminases acting on RNA (ADAR) editing; congenital Zika syndrome (CZS); innate immunity

Mesh:

Substances:

Year:  2019        PMID: 31106880      PMCID: PMC6699488          DOI: 10.1002/bies.201800239

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  126 in total

1.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

Review 2.  Molecular pathopharmacology of 5-HT2C receptors and the RNA editing in the brain.

Authors:  Michihisa Tohda; Michio Nomura; Yasuyuki Nomura
Journal:  J Pharmacol Sci       Date:  2006       Impact factor: 3.337

3.  Human coding RNA editing is generally nonadaptive.

Authors:  Guixia Xu; Jianzhi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

Review 4.  Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development.

Authors:  Laura J Yockey; Akiko Iwasaki
Journal:  Immunity       Date:  2018-09-18       Impact factor: 31.745

5.  Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons.

Authors:  Daniela Bonini; Alice Filippini; Luca La Via; Chiara Fiorentini; Fabio Fumagalli; Marina Colombi; Alessandro Barbon
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

6.  Description of 13 Infants Born During October 2015-January 2016 With Congenital Zika Virus Infection Without Microcephaly at Birth - Brazil.

Authors:  Vanessa van der Linden; André Pessoa; William Dobyns; A James Barkovich; Hélio van der Linden Júnior; Epitacio Leite Rolim Filho; Erlane Marques Ribeiro; Mariana de Carvalho Leal; Pablo Picasso de Araújo Coimbra; Maria de Fátima Viana Vasco Aragão; Islane Verçosa; Camila Ventura; Regina Coeli Ramos; Danielle Di Cavalcanti Sousa Cruz; Marli Tenório Cordeiro; Vivian Maria Ribeiro Mota; Mary Dott; Christina Hillard; Cynthia A Moore
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-02       Impact factor: 17.586

7.  Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.

Authors:  Takuto Hideyama; Takenari Yamashita; Hitoshi Aizawa; Shoji Tsuji; Akiyoshi Kakita; Hitoshi Takahashi; Shin Kwak
Journal:  Neurobiol Dis       Date:  2011-12-28       Impact factor: 5.996

Review 8.  To edit or not to edit: regulation of ADAR editing specificity and efficiency.

Authors:  Sarah N Deffit; Heather A Hundley
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-11-26       Impact factor: 9.957

9.  Dynamic regulation of RNA editing in human brain development and disease.

Authors:  Taeyoung Hwang; Chul-Kee Park; Anthony K L Leung; Yuan Gao; Thomas M Hyde; Joel E Kleinman; Anandita Rajpurohit; Ran Tao; Joo Heon Shin; Daniel R Weinberger
Journal:  Nat Neurosci       Date:  2016-06-27       Impact factor: 24.884

10.  Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.

Authors:  Richard Furie; Munther Khamashta; Joan T Merrill; Victoria P Werth; Kenneth Kalunian; Philip Brohawn; Gabor G Illei; Jorn Drappa; Liangwei Wang; Stephen Yoo
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

View more
  3 in total

1.  Automated Isoform Diversity Detector (AIDD): a pipeline for investigating transcriptome diversity of RNA-seq data.

Authors:  Noel-Marie Plonski; Emily Johnson; Madeline Frederick; Heather Mercer; Gail Fraizer; Richard Meindl; Gemma Casadesus; Helen Piontkivska
Journal:  BMC Bioinformatics       Date:  2020-12-30       Impact factor: 3.169

2.  IRE1-Mediated Unfolded Protein Response Promotes the Replication of Tick-Borne Flaviviruses in a Virus and Cell-Type Dependent Manner.

Authors:  Veronika J M Breitkopf; Gerhard Dobler; Peter Claus; Hassan Y Naim; Imke Steffen
Journal:  Viruses       Date:  2021-10-27       Impact factor: 5.048

3.  Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes.

Authors:  Stéphane Mathis; Antoine Soulages; Gwendal Le Masson; Jean-Michel Vallat
Journal:  J Neurol       Date:  2020-09-10       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.